MedPath

Contributions of dorsal and ventral neural pathways to speaking in health and disease

Recruiting
Conditions
Primaire progressieve Afasie en Taalstoornissen in het kader van neurodegeneratieve aandoeningen
Primary Progressive Aphasia (PPA)
Registration Number
NL-OMON43205
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

* Neurodegenerative disease with a Language deficit
* Dutch speaking
* Age between 20-90
* Normal or corrected-to-normal vision and hearing
* Informed consent
* An impaired performance on the SYDBAT-NL

Exclusion Criteria

* Inability to speak/understand the Dutch language.
* Current psychiatric disorder, such as psychosis or major depression
* Current substance abuse
* Current or past neurological disorder, such as severe cerebral disease, e.g. Parkinson*s disease, epilepsy, traumatic brain injury, central nervous system infection, brain tumor, and alcoholic encephalopathy. N.B. Transient Ischaemic Attack, lacunar infarction and white matter lesions are no exclusion criteria.
* Cognitive disorders in multiple other cognitive domains than language (e.g. memory or executive function deficits, as defined by cognitive test performance 2 or more standard deviation below normative scores);The exclusion criteria for undergoing an DTI scanning procedure are:
* Electronically, magnetically and mechanically activated implants (e.g. cardiac
pacemakers, defibrillators) or metallic devices (e.g. prosthetic heart valves) which
could be affected by the magnetic field
* Claustrophobia
* Loose metallic objects in the body (e.g. metallic fragments in the eyes from
occupational exposure) which could be moved by the magnetic field
* inability to lie flat comfortably in the MRI scanner for 30 minutes

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath